Avid Bioservices Inc (CDMO)

[nuke661]

dia,

just to add to your info, SK said this at the Wedbush conference:

"Again we like this combination paclitaxel again as a part of the same family that docetaxel are known to be immunostimulatory. So we certainly think this data supports moving forward at some point in future with another breast cancer study. Another study which has gotten a lot of attention is our liver cancer study in combination with sorafenib. again sorafenib very recently was shown to have immunostimulatory effects.

And so again a good combination early data from the study looks very promising. We're hoping to have more data from the study towards the end of this year early next year. As I mentioned we're also running a front-line study in combination with another chemotherapy pemetrexed. We expect data from that again towards the end of this year early next year."

http://www.earningsimpact.com/Transcript/82836/PPHM/Peregrine-Pharmaceuticals---Wedbush-2013-Life-Sciences-Management-Access-Conference/Page/6#sthash.VO3Bl2ay.dpbs